Madison Capital Funding closed a senior debt facility to finance the Recapitalization of LifeSpan BioSciences, Inc. by Thompson Street Capital Partners. Madison Capital Funding was the Sole Lead Arranger and Administrative Agent. Further terms were not disclosed.
LifeSpan BioSciences, Inc. is a provider and distributor of antibodies and reagents to the pharma and academia research end markets.
Founded in 2001, Madison Capital Funding is a market leader in supporting middle market private equity sponsors with cash-flow based corporate finance products. Since inception, Madison Capital Funding has invested $33.2 billion in 1,167 middle market transactions with 303 private equity sponsors.
The loan discussed does not represent an account’s entire portfolio and in the aggregate, may represent only a small percentage of an account’s portfolio holdings. A complete list of all holdings is available upon request; please contact firstname.lastname@example.org. It should not be assumed that recommendations made in the future will be profitable or will equal the performance of the loans mentioned herein. © 2019 Madison Capital Funding LLC. All rights reserved. Madison Capital Funding LLC is a subsidiary of New York Life Insurance Company. MCF #1817592